RxWare Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$700K
- Investors
-
18
RxWare General Information
Description
Developer of a mobile intelligence platform designed to offer a complete technology framework for personalizing existing patient services. The company's platform provides a search tool for people with type 1, type 2, and gestational diabetes in order to get to know about the symptoms of diabetes, how to lower their a1c, and learn more about diabetes diet and management, enabling drug manufacturers toto streamline and accelerate the entire patient journey.
Contact Information
Website
www.rxware.ioCorporate Office
- 1313 North Market Street
- Suite 5100
- Wilmington, DE 19801
- United States
Corporate Office
- 1313 North Market Street
- Suite 5100
- Wilmington, DE 19801
- United States
RxWare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 07-May-2024 | $700K | Completed | Generating Revenue | ||
| 5. Later Stage VC | 01-Sep-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A1) | 22-Jan-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 13-Dec-2017 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 07-Sep-2015 | $750K | Completed | Generating Revenue | ||
| 1. Seed Round | 18-Jul-2014 | $750K | $750K | Completed | Generating Revenue |
RxWare Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 609,212 | $0.000100 | $0.14 | $1.78 | $1.78 | 1x | $1.78 | 9.2% |
| Series A-2 | 542,529 | $0.000100 | $0.12 | $1.55 | $1.55 | 1x | $1.55 | 8.19% |
RxWare Comparisons
Industry
Financing
Details
RxWare Competitors (31)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 98point6 | Formerly VC-backed | Seattle, WA | ||||
| Welldoc | Venture Capital-Backed | Columbia, MD | ||||
| Noom | Venture Capital-Backed | New York, NY | ||||
| Zipnosis | Formerly VC-backed | Minneapolis, MN | ||||
| Lark | Venture Capital-Backed | Mountain View, CA |
RxWare Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RxWare Patents
RxWare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160357928-A1 | Contextual patient support | Inactive | 06-Jun-2015 | ||
| US-9830394-B2 | Help service for identifying relevant resources across a community and social data streams | Active | 01-May-2013 | ||
| US-20140330842-A1 | Method for identifying relevant individuals by cross-searching social data streams | Active | 01-May-2013 | ||
| US-20180039642-A1 | Method for identifying relevant individuals by cross-searching social data streams | Inactive | 01-May-2013 | G06F16/9537 |
RxWare Executive Team (6)
| Name | Title | Board Seat |
|---|---|---|
| Yishai Knobel | Co-Founder, Board Member & Chief Executive Officer | |
| Shlomi Aflalo | Co-Founder, Board Member & Chief Technology Officer | |
| Sonny Vu Ph.D | Advisor | |
| Vanessa Bartram | Advisor |
RxWare Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam Fine | Windham Capital Partners | Board Member | |
| David Matias | Self | Board Member | |
| Gregg Dearhammer | Self | Board Member | |
| Harry Totonis | ConnectiveRx | Board Member | |
| Ori Karev JD | Self | Chairman of the Board & Advisor |
RxWare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RxWare Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adam Fine | Angel (individual) | Minority | ||
| Calin Fusu | Angel (individual) | Minority | ||
| Chris Bergstrom | Angel (individual) | Minority | ||
| ConnectiveRx | PE-Backed Company | Minority | ||
| IQVIA | Corporation | Minority |
RxWare FAQs
-
When was RxWare founded?
RxWare was founded in 2013.
-
Who is the founder of RxWare?
Yishai Knobel and Shlomi Aflalo are the founders of RxWare.
-
Who is the CEO of RxWare?
Yishai Knobel is the CEO of RxWare.
-
Where is RxWare headquartered?
RxWare is headquartered in Wilmington, DE.
-
What is the size of RxWare?
RxWare has 31 total employees.
-
What industry is RxWare in?
RxWare’s primary industry is Practice Management (Healthcare).
-
Is RxWare a private or public company?
RxWare is a Private company.
-
What is RxWare’s current revenue?
The current revenue for RxWare is .
-
How much funding has RxWare raised over time?
RxWare has raised $7.45M.
-
Who are RxWare’s investors?
Adam Fine, Calin Fusu, Chris Bergstrom, ConnectiveRx, and IQVIA are 5 of 18 investors who have invested in RxWare.
-
Who are RxWare’s competitors?
98point6, Welldoc, Noom, Zipnosis, and Lark are some of the 31 competitors of RxWare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
